Wouldn't go that far, but we are certainly right around the 52 week low of .40 cents. Looking forward to something that will lift us out of this hole. NuGenerex should be wrapping up the testing of those peptides soon.

From one of the last PR’s: “Over the next few weeks leading to the shareholders’ call, we will provide additional information in separate announcements outlining the details of these new initiatives including the telehealth venture, the ALTuCell acquisition, and the closing of three funding instruments.”